Navigation Links
Caliper Life Sciences Launches Living Image(R) 4.0 Software

HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide. Living Image 4.0 features advanced spectral unmixing tools to enhance fluorescent sensitivity and automated 3D image acquisition and analysis providing an anatomical view of disease activity and drug efficacy.

Preclinical imaging for translational research is now routinely used in large scale studies for drug discovery and vaccine development. With Living Image 4.0, scientists can easily visualize and track diseases quantitatively, in small living animals through the sensitive detection of fluorescent and bioluminescent reporters and functional markers. 3D images generated with Living Image 4.0 can also be co-registered with CT or MRI results to provide enhanced anatomical context for optical molecular signals.

The software's new design creates an intuitive, seamless workflow for researchers of all skill levels. New features include: wizard based guidance for advanced imaging protocols, improved surface tomography, advanced spectral unmixing tools, new color templates and 3D visualization tools. All IVIS systems are calibrated to NIST standards to ensure that quantitative results are validated throughout an experiment and from location to location.

"Caliper's IVIS systems are widely recognized as the leading small animal molecular imaging instrument for drug discovery and development," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "Living Image 4.0 will further enhance IVIS's value to scientists by improving its ease-of-use, quantitation and reproducibility."

Living Image 4.0 began shipping with all new IVIS in vivo imaging systems on November 30, 2009. Upgrades to Living Image 4.0 for existing IVIS systems will be available for purchase January 1, 2010.

For additional information on Caliper's portfolio of optical imaging systems, please visit

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit

Caliper, Living Image and IVIS are registered trademarks of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems
2. Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray
3. Caliper Life Sciences Reports Second Quarter 2009 Results
4. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
5. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
6. Caliper Life Sciences to Webcast Investor Session of Open House
7. Caliper Life Sciences Reports First Quarter 2009 Results
8. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
9. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
10. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... device company specializing in imaging technologies, announced today that it ... as part of the Horizon 2020 European Union Framework Programme ... a large-scale clinical trial in breast cancer. , ... , --> --> The ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
Breaking Biology News(10 mins):